Effects of Motor Control Exercises With and Without Pressure Biofeedback in Recurrent Low Back Pain (MCE) (yes)
Effects of Motor Control With and Without Pressure Biofeedback-Guided Training on Pain, Transversus Abdominis Activation and Disability in Patients With Recurrent Low Back Pain
This study aims to compare the effects of Motor Control Exercises (MCE) with and without Pressure Biofeedback-Guided Training in patients with recurrent low back pain. It will evaluate the effectiveness of both interventions in reducing pain, improving Transversus abdominis (TrA) muscle activation, and decreasing disability. The study will determine whether adding pressure biofeedback to motor control exercises provides better clinical outcomes than motor control exercises alone.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- University of Management & Technology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged 18-45 years with recurrent low back pain
- Both male and female participants
- Mild to moderate low back pain with a NPRS Scale score of 3-6 out of 10
- History of at least two episodes of low back pain within the past 12 months
- Absence of radiating pain below the gluteal fold
- Ability to perform the Abdominal Drawing-In Maneuver (ADIM)
Exclusion Criteria:
- Specific low back pain attributable to identifiable pathological conditions
- Active lumbar radiculopathy accompanied by neurological deficits
- Referred or radiating pain extending below the gluteal fold
- Diagnosed spinal conditions, including disc herniation, spinal stenosis,
- Medical conditions potentially associated with low back pain e.g tumors
- History of surgery for low back pain within the past 12 months
- Pregnancy
- Current participation in another physiotherapy or rehabilitation program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Motor Control Training with Pressure Bio-feedback
|
Participants will receive 45-minute sessions comprising a 5-minute warm-up, 35-minute Motor Control Exercises (MCE), and 5-minute cool-down, guided by Pressure Biofeedback (PBU). Weeks 1-2: ADIM, diaphragmatic breathing, multifidus activation, and heel slides (2-3 sets × 10 repetitions). Weeks 3-4: Straight leg raises, double-leg lowering, bridging, and quadruped arm/leg extensions (3 sets × 8-10 repetitions). Weeks 5-6: Standing ADIM, partial squats, planks, and sit-to-stand exercises (3 sets × 10 repetitions; planks 20-45 seconds). |
|
Active Comparator: Motor Control Training
|
Participants will receive the same 45-minute Motor Control Exercise (MCE) program as in experimental group, including warm-up, phased exercises (Weeks 1-6), and cool-down, with identical sets, repetitions, hold times, rest intervals, and progression criteria, but without Pressure Biofeedback (PBU). Standardized verbal instructions and tactile cues (TrA palpation) will guide muscle activation. The same physiotherapist will supervise both groups, with exercise completion and adverse events recorded in session logs. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain Rating Scale
Time Frame: Baseline, 3 weeks and 6 weeks post treatment
|
Pain intensity will be assessed using the Numeric Pain Rating Scale, an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Scores of 1-3 indicate mild pain, 4-6 indicate moderate pain, and 7-10 indicate severe pain. Higher scores indicate greater pain intensity and a worse outcome, while lower scores indicate less pain and a better outcome. |
Baseline, 3 weeks and 6 weeks post treatment
|
|
Revised Oswestry Disability Questionnaire
Time Frame: Baseline, 3 weeks and 6 weeks post treatment
|
The Revised Oswestry Disability Questionnaire is a valid and reliable 10-item questionnaire. Each item is scored 0-5, with total disability expressed as a percentage: 0-20% (minimal), 21-40% (moderate), 41-60% (severe), 61-80% (crippled/severe functional limitation), and 81-100% (very severe disability). Higher scores indicate greater disability. |
Baseline, 3 weeks and 6 weeks post treatment
|
|
Rehabilitative Ultrasound Imaging
Time Frame: Baseline, 3 weeks and 6 weeks post treatment
|
Rehabilitative Ultrasound Imaging (RUSI) is a non-invasive, reliable technique used to assess deep trunk muscle morphology, thickness, and activation. Transversus Abdominis (TrA) activation will be evaluated by measuring muscle thickness at rest and during contraction. Changes in muscle thickness will serve as an indirect indicator of muscle activation and lumbopelvic stability. |
Baseline, 3 weeks and 6 weeks post treatment
|
|
Pressure Biofeedback
Time Frame: Baseline, 3 weeks and 6 weeks post treatment
|
The Pressure Biofeedback Unit (PBU) is a non-invasive device consisting of an inflatable pressure cell and gauge that provides visual feedback to improve lumbopelvic control during motor control exercises. It helps enhance abdominal muscle recruitment, reduce lumbopelvic instability, and improve movement control in patients with chronic low back pain. |
Baseline, 3 weeks and 6 weeks post treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RE-167-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
6 months after the publication of the manuscript.
IPD Sharing Access Criteria
The data can be requested from the corresponding author
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.